1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow RAD001: new trials by email Literature Review of RAD001 trials Research Report on RAD001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy Everolimus, Laboratory Biomarker Analysis, Survey Administration - Salivary Gland Dysfunction, Xerostomia | Early Phase 1 | Terminated | University of Arizona | 2 | 2018-05-04 | 2019-12-02 |
| Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas RAD001 - Neurofibromatosis Type 2, Vestibular Schwannomas | Early Phase 1 | Completed | NYU Langone Health | 5 | 2013-06-01 | 2020-05-13 |
Head and Neck Neoplasms (1) · Meningioma (1) · Mouth Neoplasms (1) · Neurofibromatosis 2 (1) · Neuroma, Acoustic (1) · Xerostomia (1)
NYU Langone Health (1) · University of Arizona (1)
United States (2)
Panayiotis Savvides (1) · Theodore Nicolaides, MD (1)
P30CA023074 (1)